001     176989
005     20240229133727.0
024 7 _ |a 10.20517/jtgg.2021.08
|2 doi
024 7 _ |a pmid:34622145
|2 pmid
024 7 _ |a pmc:PMC8494431
|2 pmc
024 7 _ |a altmetric:114732349
|2 altmetric
037 _ _ |a DKFZ-2021-02222
041 _ _ |a English
100 1 _ |a Moore, Amy
|b 0
245 _ _ |a Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes.
260 _ _ |a Erscheinungsort nicht ermittelbar
|c 2021
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1693388903_15639
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Journal of Translational Genetics and Genomics (jtgg) = 2578-5281 (import from CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de)
520 _ _ |a Recessive genetic variation is thought to play a role in non-Hodgkin lymphoma (NHL) etiology. Runs of homozygosity (ROH), defined based on long, continuous segments of homozygous SNPs, can be used to estimate both measured and unmeasured recessive genetic variation. We sought to examine genome-wide homozygosity and NHL risk.We used data from eight genome-wide association studies of four common NHL subtypes: 3061 chronic lymphocytic leukemia (CLL), 3814 diffuse large B-cell lymphoma (DLBCL), 2784 follicular lymphoma (FL), and 808 marginal zone lymphoma (MZL) cases, as well as 9374 controls. We examined the effect of homozygous variation on risk by: (1) estimating the fraction of the autosome containing runs of homozygosity (FROH); (2) calculating an inbreeding coefficient derived from the correlation among uniting gametes (F3); and (3) examining specific autosomal regions containing ROH. For each, we calculated beta coefficients and standard errors using logistic regression and combined estimates across studies using random-effects meta-analysis.We discovered positive associations between FROH and CLL (β = 21.1, SE = 4.41, P = 1.6 × 10-6) and FL (β = 11.4, SE = 5.82, P = 0.02) but not DLBCL (P = 1.0) or MZL (P = 0.91). For F3, we observed an association with CLL (β = 27.5, SE = 6.51, P = 2.4 × 10-5). We did not find evidence of associations with specific ROH, suggesting that the associations observed with FROH and F3 for CLL and FL risk were not driven by a single region of homozygosity.Our findings support the role of recessive genetic variation in the etiology of CLL and FL; additional research is needed to identify the specific loci associated with NHL risk.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a Non-Hodgkin lymphoma
|2 Other
650 _ 7 |a chronic lymphocytic leukemia
|2 Other
650 _ 7 |a diffuse large B-cell lymphoma
|2 Other
650 _ 7 |a follicular lymphoma
|2 Other
650 _ 7 |a homozygosity
|2 Other
650 _ 7 |a marginal zone lymphoma
|2 Other
700 1 _ |a Machiela, Mitchell J
|b 1
700 1 _ |a Machado, Moara
|b 2
700 1 _ |a Wang, Sophia S
|b 3
700 1 _ |a Kane, Eleanor
|b 4
700 1 _ |a Slager, Susan L
|b 5
700 1 _ |a Zhou, Weiyin
|b 6
700 1 _ |a Carrington, Mary
|b 7
700 1 _ |a Lan, Qing
|b 8
700 1 _ |a Milne, Roger L
|b 9
700 1 _ |a Birmann, Brenda M
|b 10
700 1 _ |a Adami, Hans-Olov
|b 11
700 1 _ |a Albanes, Demetrius
|b 12
700 1 _ |a Arslan, Alan A
|b 13
700 1 _ |a Becker, Nikolaus
|0 P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab
|b 14
|u dkfz
700 1 _ |a Benavente, Yolanda
|b 15
700 1 _ |a Bisanzi, Simonetta
|b 16
700 1 _ |a Boffetta, Paolo
|b 17
700 1 _ |a Bracci, Paige M
|b 18
700 1 _ |a Brennan, Paul
|b 19
700 1 _ |a Brooks-Wilson, Angela R
|b 20
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 21
|u dkfz
700 1 _ |a Caporaso, Neil
|b 22
700 1 _ |a Clavel, Jacqueline
|b 23
700 1 _ |a Cocco, Pierluigi
|b 24
700 1 _ |a Conde, Lucia
|b 25
700 1 _ |a Cox, David G
|b 26
700 1 _ |a Cozen, Wendy
|b 27
700 1 _ |a Curtin, Karen
|b 28
700 1 _ |a De Vivo, Immaculata
|b 29
700 1 _ |a de Sanjose, Silvia
|b 30
700 1 _ |a Foretova, Lenka
|b 31
700 1 _ |a Gapstur, Susan M
|b 32
700 1 _ |a Ghesquières, Hervè
|b 33
700 1 _ |a Giles, Graham G
|b 34
700 1 _ |a Glenn, Martha
|b 35
700 1 _ |a Glimelius, Bengt
|b 36
700 1 _ |a Gao, Chi
|b 37
700 1 _ |a Habermann, Thomas M
|b 38
700 1 _ |a Hjalgrim, Henrik
|b 39
700 1 _ |a Jackson, Rebecca D
|b 40
700 1 _ |a Liebow, Mark
|b 41
700 1 _ |a Link, Brian K
|b 42
700 1 _ |a Maynadie, Marc
|b 43
700 1 _ |a McKay, James
|b 44
700 1 _ |a Melbye, Mads
|b 45
700 1 _ |a Miligi, Lucia
|b 46
700 1 _ |a Molina, Thierry J
|b 47
700 1 _ |a Monnereau, Alain
|b 48
700 1 _ |a Nieters, Alexandra
|b 49
700 1 _ |a North, Kari E
|b 50
700 1 _ |a Offit, Kenneth
|b 51
700 1 _ |a Patel, Alpa V
|b 52
700 1 _ |a Piro, Sara
|b 53
700 1 _ |a Ravichandran, Vignesh
|b 54
700 1 _ |a Riboli, Elio
|b 55
700 1 _ |a Salles, Gilles
|b 56
700 1 _ |a Severson, Richard K
|b 57
700 1 _ |a Skibola, Christine F
|b 58
700 1 _ |a Smedby, Karin E
|b 59
700 1 _ |a Southey, Melissa C
|b 60
700 1 _ |a Spinelli, John J
|b 61
700 1 _ |a Staines, Anthony
|b 62
700 1 _ |a Stewart, Carolyn
|b 63
700 1 _ |a Teras, Lauren R
|b 64
700 1 _ |a Tinker, Lesley F
|b 65
700 1 _ |a Travis, Ruth C
|b 66
700 1 _ |a Vajdic, Claire M
|b 67
700 1 _ |a Vermeulen, Roel C H
|b 68
700 1 _ |a Vijai, Joseph
|b 69
700 1 _ |a Weiderpass, Elisabete
|b 70
700 1 _ |a Weinstein, Stephanie
|b 71
700 1 _ |a Doo, Nicole Wong
|b 72
700 1 _ |a Zhang, Yawei
|b 73
700 1 _ |a Zheng, Tongzhang
|b 74
700 1 _ |a Chanock, Stephen J
|b 75
700 1 _ |a Rothman, Nathaniel
|b 76
700 1 _ |a Cerhan, James R
|b 77
700 1 _ |a Dean, Michael
|b 78
700 1 _ |a Camp, Nicola J
|b 79
700 1 _ |a Yeager, Meredith
|b 80
700 1 _ |a Berndt, Sonja I
|b 81
773 _ _ |a 10.20517/jtgg.2021.08
|g Vol. 5
|0 PERI:(DE-600)3104319-7
|p 200-217
|t Journal of Translational Genetics and Genomics
|v 5
|y 2021
|x 2578-5281
909 C O |p VDB
|o oai:inrepo02.dkfz.de:176989
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21